Detalhe da pesquisa
1.
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.
J Endocrinol Invest;
47(2): 433-442, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37592052
2.
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.
J Endocrinol Invest;
47(3): 759, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37814065
3.
[Traumatic events and stress responses: the role of oxytocin and attachment]. / Evénements traumatiques et réponses de stress: le rôle de l'ocytocine et de l'attachement.
Rev Med Suisse;
9(398): 1678-81, 2013 Sep 18.
Artigo
em Francês
| MEDLINE
| ID: mdl-24164018
4.
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.
Ann Oncol;
21(10): 1974-1981, 2010 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20332136
5.
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer.
Ann Oncol;
20(7): 1178-84, 2009 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19218304
6.
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Breast Cancer Res Treat;
118(2): 385-94, 2009 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19562480
7.
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity.
Br J Cancer;
99(10): 1564-71, 2008 Nov 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18941458
8.
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer.
Br J Cancer;
98(11): 1745-52, 2008 Jun 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18506176
9.
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy.
Ann Oncol;
19(3): 465-72, 2008 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17986623
10.
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
Ann Oncol;
19(7): 1231-1241, 2008 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18325918
11.
Developmental delay in communication among toddlers and its relationship to caregiving behavior among violence-exposed, posttraumatically stressed mothers.
Res Dev Disabil;
82: 67-78, 2018 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29754762
12.
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer.
Ann Oncol;
18(10): 1632-40, 2007 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17716986
13.
Fulvestrant for advanced male breast cancer patients: a case series.
Ann Oncol;
22(4): 985, 2011 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21447621
14.
A phase II study of primary dose-dense sequential doxorubicin plus cyclophosphamide and docetaxel in cT4 breast cancer.
Anticancer Res;
26(5B): 3861-4, 2006.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17094414
15.
Effect of the synthetic retinoid fenretinide on dark adaptation and the ocular surface.
J Natl Cancer Inst;
86(2): 105-10, 1994 Jan 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-8271292
16.
The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients.
Cancer Res;
53(20): 4769-71, 1993 Oct 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-8402658
17.
Lapatinib and metronomic capecitabine combination in an HER2-positive inflammatory breast cancer patient: a case report.
Ann Oncol;
21(3): 667-668, 2010 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20032127
18.
Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patients.
Cancer Epidemiol Biomarkers Prev;
3(6): 507-10, 1994 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-8000302
19.
Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
Cancer Epidemiol Biomarkers Prev;
9(10): 1071-8, 2000 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11045790
20.
Correlation between plasma transforming growth factor-beta 1 and second primary breast cancer in a chemoprevention trial.
Eur J Cancer;
34(7): 999-1003, 1998 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-9849446